Publication | Closed Access
Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study
2.2K
Citations
28
References
2020
Year
Hematological MalignancyLymphoid NeoplasiaOncologyTranscend Nhl 001Lisocabtagene MaraleucelMedicineRadiation OncologyCancer Research
| Year | Citations | |
|---|---|---|
Page 1
Page 1